The following transcript has been edited for clarity.

Hi, I'm Devinder Chauhan, MD, FRCOphth, FRANZCO, a retina specialist from Melbourne, Australia. We've just completed the Focus A-Eye 2026 Summit, the day before ARVO formally starts. The session I was involved in was called "Lessons from Formula One: Optimizing Clinical Workflow with AI."

There were 4 speakers. I personally spoke about decision support software in the treatment of macular degeneration, bringing in all the different roles and data sources into 1 place where doctors can see everything they need to do in just 1 spot. Kerry E. Ashby from the Collaborative Community on Ophthalmic Innovation (CCOI) spoke about interoperability and the importance of having all the data in 1 place that the retina specialist or any ophthalmologist can see so that they can make good decisions. Bob Gibson talked about how Zeiss has brought in lots of different AI components to much of their product range over the last several years, all of which are centered on workflow. And finally, Murtaza Adam, MD, who was talking on behalf of Lumata Health, discussed what happens outside of the clinic, such that the patients are better informed and more adherent to treatment, which obviously means better clinical outcomes.

We had a discussion at the end about how to get clinics to adopt these new solutions and what the barriers were. The takeaway was primarily that it was about interrupting workflow and the perception that it might take more time or be more clicks or more difficult. And also the other issue was essentially having multiple devices, multiple pieces of software, and needing them all to speak with each other. RP